Ledger.Open graph →
SEC Form D · filed November 21, 2025

Strategikon Pharma, Inc

Offering
$3.0M
Sold
$2.3M
Exemption
Rule 506(b)
Industry
Other Technology
Location
San Francisco, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Anca Copaescu · San Francisco, CAExec · DirectorChris Codeanne · San Francisco, CADirectorPaulo Carvalho · San Francisco, CAExecMark Weinstein · San Francisco, CAExec · DirectorNathanael Lentz · Milpitas, CADirectorRob Hess · San Francisco, CADirectorDebra Apruzzese · San Francisco, CADirectorVincent Lepreux · San Francisco, CADirectorRob Hess · San Francisco, CADirectorAnca Copaescu · San Francisco, CAExec · DirectorDebra Apruzzese · San Francisco, CADirectorChris Codeanne · San Francisco, CADirectorPaulo Carvalho · San Francisco, CAExecVincent Lepreux · San Francisco, CADirectorMark Weinstein · CULVER CITY, CAExec · DirectorNathanael Lentz · Nashua, NHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗